Metastasis-associated mutations in clear cell renal cell carcinoma. This is an ASCO Meeting Abstract from the 2016 Genitourinary Cancers Symposium. This abstract does not include a full text component ...
Prescriber treatment patterns for tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin (mTOR) inhibitors in patients with renal cell carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback